Company Intelligence
Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their…
Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials.
We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Empowering every doctor and every patient to participate in research
Novelcare was founded in 2023 per the company profile source on file.
SourceAn evergreen landscape report of 14 verified AI companies in Healthcare covered on Brel Digital, grounded in company…
View ReportA verified landscape of AI companies on Brel Digital tagged for the Clinical Documentation use case, citing official…
View ReportA verified landscape of AI companies on Brel Digital tagged for Generative AI, citing official sources already on…
View ReportA verified landscape of AI companies on Brel Digital tagged for Large Language Models (LLMs), citing official sources…
View ReportEvergreen insight linking verified Brel companies tagged for Medical Imaging, with official sources on file.
Read InsightEvergreen insight linking verified Brel companies tagged for Ambient Scribing, with official sources on file.
Read InsightEvergreen insight linking verified Brel companies tagged for Clinical Documentation, with official sources on file.
Read InsightEvergreen insight linking verified Brel companies tagged for Recruiting & Talent, with official sources on file.
Read InsightNovelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials.
We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We’re on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.
Request a correction if you represent this company or believe information is inaccurate.
